TERN-501
- United States
Terns Pharmaceuticals to Present Data on Multiple NASH Programs at The Digital International Liver Congress™ 2020
Foster City, Calif., United States: -Single doses of TERN-201 were safe and well tolerated and demonstrated potent, selective, and sustained…
Read More »